Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Position paper of Italian rheumatologists on the use of biosimilar drugs.

Atzeni F, Sebastiani M, Ricci C, Celano A, Gremese E, Iannone F, Meroni PL, Minghetti P, Sarzi-Puttini P, Ferraccioli G, Lapadula G.

Clin Exp Rheumatol. 2015 Jan-Feb;33(1):1-4. Epub 2014 Nov 7.

PMID:
25436597
2.

Emerging complexity and possible new approaches from a patients' perspective.

Iardino R, Celano A.

Ann Ist Super Sanita. 2011;47(1):109. doi: 10.4415/ANN_11_01_22. No abstract available.

3.

Elaboration of the preliminary Rheumatoid Arthritis Impact of Disease (RAID) score: a EULAR initiative.

Gossec L, Dougados M, Rincheval N, Balanescu A, Boumpas DT, Canadelo S, Carmona L, Daurès JP, de Wit M, Dijkmans BA, Englbrecht M, Gunendi Z, Heiberg T, Kirwan JR, Mola EM, Matucci-Cerinic M, Otsa K, Schett G, Sokka T, Wells GA, Aanerud GJ, Celano A, Dudkin A, Hernandez C, Koutsogianni K, Akca FN, Petre AM, Richards P, Scholte-Voshaar M, Von Krause G, Kvien TK.

Ann Rheum Dis. 2009 Nov;68(11):1680-5. doi: 10.1136/ard.2008.100271. Epub 2008 Dec 3.

PMID:
19054825
4.

Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly study.

Maione P, Perrone F, Gallo C, Manzione L, Piantedosi F, Barbera S, Cigolari S, Rosetti F, Piazza E, Robbiati SF, Bertetto O, Novello S, Migliorino MR, Favaretto A, Spatafora M, Ferraù F, Frontini L, Bearz A, Repetto L, Gridelli C, Barletta E, Barzelloni ML, Iaffaioli RV, De Maio E, Di Maio M, De Feo G, Sigoriello G, Chiodini P, Cioffi A, Guardasole V, Angelini V, Rossi A, Bilancia D, Germano D, Lamberti A, Pontillo V, Brancaccio L, Renda F, Romano F, Esani G, Gambaro A, Vinante O, Azzarello G, Clerici M, Bollina R, Belloni P, Sannicolò M, Ciuffreda L, Parello G, Cabiddu M, Sacco C, Sibau A, Porcile G, Castiglione F, Ostellino O, Monfardini S, Stefani M, Scagliotti G, Selvaggi G, De Marinis F, Martelli O, Gasparini G, Morabito A, Gattuso D, Colucci G, Galetta D, Giotta F, Gebbia V, Borsellino N, Testa A, Malaponte E, Capuano MA, Angiolillo M, Sollitto F, Tirelli U, Spazzapan S, Adamo V, Altavilla G, Scimone A, Hopps MR, Tartamella F, Ianniello GP, Tinessa V, Failla G, Bordonaro R, Gebbia N, Valerio MR, D'Aprile M, Veltri E, Tonato M, Darwish S, Romito S, Carrozza F, Barni S, Ardizzoia A, Corradini GM, Pavia G, Belli M, Colantuoni G, Galligioni E, Caffo O, Labianca R, Quadri A, Cortesi E, D'Auria G, Fava S, Calcagno A, Luporini G, Locatelli MC, Di Costanzo F, Gasperoni S, Isa L, Candido P, Gaion F, Palazzolo G, Nettis G, Annamaria A, Rinaldi M, Lopez M, Felletti R, Di Negro GB, Rossi N, Calandriello A, Maiorino L, Mattioli R, Celano A, Schiavon S, Illiano A, Raucci CA, Caruso M, Foa P, Tonini G, Curcio C, Cazzaniga M.

J Clin Oncol. 2005 Oct 1;23(28):6865-72.

5.

Clinical and pharmacokinetic phase II study of pegylated liposomal doxorubicin and vinorelbine in heavily pretreated recurrent ovarian carcinoma.

Katsaros D, Oletti MV, Rigault de la Longrais IA, Ferrero A, Celano A, Fracchioli S, Donadio M, Passera R, Cattel L, Bumma C.

Ann Oncol. 2005 Feb;16(2):300-6.

6.

Supportive care in patients with advanced non-small-cell lung cancer.

Di Maio M, Perrone F, Gallo C, Iaffaioli RV, Manzione L, Piantedosi FV, Cigolari S, Illiano A, Barbera S, Robbiati SF, Piazza E, Ianniello GP, Frontini L, Veltri E, Castiglione F, Rosetti F, De Maio E, Maione P, Gridelli C, Rossi A, Barletta E, Barzelloni ML, Signoriello G, Bilancia D, Dinota A, Rosati G, Germano D, Lamberti A, Pontillo V, Brancacio L, Crispino C, Esposito M, Battiloro C, Tufano G, Cioffi A, Guardasole V, Angelini V, Guidetti G, Barbera S, Renda F, Romano F, Volpintesta A, Robbiati SF, Sannicolò M, Filipazzi V, Esani G, Gambaro A, Ferrario S, Tinessa V, Caprio MG, Zonato S, Cabiddu M, Raina A, Veltri E, D'Aprile M, Pistillucci G, Porcile G, Ostellino O, Vinante O, Azzarello G, Gebbia V, Borsellino N, Testa A, Gasparini G, Morabito A, Gattuso D, Romito S, Carrozza F, Fava S, Calcagno A, Grimi E, Bertetto O, Ciuffreda L, Parello G, Maiorino L, Santoro A, Santoro M, Failla G, Aiello RA, Bearz A, Sorio R, Scalone S, Clerici M, Bollina R, Belloni P, Sacco C, Sibau A, Adamo V, Altavilla G, Scimone A, Spatafora M, Bellia V, Hopps MR, Monfardini S, Favaretto A, Stefani M, Corradini GM, Pavia G, Scagliotti G, Novello S, Selvaggi G, Tonato M, Darwish S, Michetti G, Belometti MO, Labianca R, Quadri A, De Marinis F, Migliorino MR, Martelli O, Colucci G, Galetta D, Giotta F, Isa L, Candido P, Rossi N, Calandriello A, Ferraù F, Malaponte E, Barni S, Cazzaniga M, Gebbia N, Valerio MR, Belli M, Colantuoni G, Capuano MA, Angiolillo M, Sollitto F, Ardizzoia A, Luporini G, Locatelli MC, Pari F, Aitini E, Pedicini T, Febbraro A, Zollo C, Di Costanzo F, Bartolucci R, Gasperoni S, Gaion F, Palazzolo G, Galligioni E, Caffo O, Cortesi E, D'Auria G, Curcio C, Vasta M, Bumma C, Celano A, Bretti S, Nettis G, Anselmo A, Mattioli R, Nisticò C, Aschelter A, Foa P.

Br J Cancer. 2003 Sep 15;89(6):1013-21.

7.

Gemcitabine plus cisplatin in the treatment of patients with advanced non-small cell lung cancer: a phase II study.

Bretti S, Manzin E, Loddo C, Berruti A, Bombaci S, Vellani G, Celano A.

Anticancer Res. 2002 Sep-Oct;22(5):3039-43.

PMID:
12530039
8.

Low dose carboplatin (AUC 4.5) combined with vinorelbine in the treatment of advanced non-small cell lung cancer: a single institution phase II study.

Bretti S, Manzin E, Celano A, Ritorto G, Loddo C, Berruti A.

Oncol Rep. 2001 Mar-Apr;8(2):381-5.

PMID:
11182060
9.

[Genetic damage in human tumors associated with particular behavioral or occupational exposures].

Celano A, Valenti D, Vineis P.

Epidemiol Prev. 1997 Apr-Jun;21(2):106-13. Review. Italian.

PMID:
9378177
10.

Value of Ki-67 immunostaining in preoperative biopsies of carcinomas of the lung.

Viberti L, Papotti M, Abbona GC, Celano A, Filosso PL, Bussolati G.

Hum Pathol. 1997 Feb;28(2):189-92.

PMID:
9023401
11.

Multicenter Phase II trial of intermediate dose cisplatin and vinorelbine in inoperable non-small cell lung cancer patients.

Bretti S, Berruti A, Gorzegno G, La Ciura P, Pazè E, Celano A, Grecchi G, Perroni D, Bumma C, Dogliotti L.

Lung Cancer. 1996 Jun;14(2-3):353-60.

PMID:
8794416
12.

Non small cell lung cancer treatment with vinorelbine monochemotherapy: a phase II study.

Clerici M, Bretti S, Celano A, Panvini D, Comandone A, Casadio C, Luporini G, Bumma C.

Anticancer Res. 1995 Mar-Apr;15(2):477-8.

PMID:
7763025
13.

[A clinical analysis of a group of Down's patients].

Cozza P, Celano A, Forlini A.

Minerva Stomatol. 1993 Apr;42(4):157-67. Italian.

PMID:
8413097
14.

Non small cell lung cancer treatment with carboplatin and vindesine: a phase II study.

Bretti S, Bonardi GM, Celano A, Comandone A, Casadio C, Marchisio U, Forconi G, Manzoni S, Bumma C.

Anticancer Res. 1992 Sep-Oct;12(5):1459-61.

PMID:
1332578

Supplemental Content

Loading ...
Support Center